Streetbeat News

Products Services

NVO

The European Medicines Agency (EMA) has announced that Novo Nordisk will temporarily reduce the supply of Victoza to facilitate an increased supply of Ozempic. Novo Nordisk has informed that the shortage of both Ozempic and Victoza is expected to worsen in Q4 2023.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:20 pm

SEED

Origin Agritech Ltd. (NASDAQ:SEED) provided a business update for FY23, expecting revenue of $12M-$13M, a 60%-70% increase from FY22. Net income is projected at $16M-$17M, including a one-time $19M gain from a building sale. Operating profit is anticipated to be around $2M. The company highlighted advancements in agricultural biotechnology, including a triple-stack trait corn and a novel gene editing method. They also discussed the potential approval of GMO corn hybrids in 2024, advancements in nitrogen-efficient corn, and expansion plans for nutrition-enhanced corn (NEC). The company is in discussions with Muyuan Foods for potential collaborations and expects to expand NEC corn planting. Origin Agritech's CEO expressed confidence in the company's future and dissatisfaction with the current stock price, indicating it undervalues the company's potential.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:19 pm

SST

System1 has introduced a new Proof of Delivery feature for its RoadWarrior app, enhancing package delivery verification. Additionally, RoadWarrior has launched a new marketplace for subscription add-ons, aiming to expand its service offerings and provide more customization options for users.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:19 pm

MSFT

TSM

Industry sources report that TSMC is providing not only the 5nm fabrication process but also backend CoWoS packaging for Microsoft's newly released Azure Maia 100 AI Accelerator.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:17 pm

HIBB

Hibbett, Inc. (NASDAQ:HIBB) shares surged after reporting Q3 sales of $431.92 million, surpassing analyst expectations of $416.02 million. Despite a slight 0.3% Y/Y net sales decrease, the company's Q3 EPS of $2.05 exceeded estimates of $1.17. E-commerce sales grew by 12.6% Y/Y, while brick-and-mortar sales fell by 5.4%. Gross margin slightly declined due to higher promotional activity. Hibbett opened ten new stores, updated its FY24 EPS outlook to $8.00-$8.30 from $7.00-$7.75, and expects total sales to be flat to up ~2.0% for FY24. The stock price rose by 16.56% to $62.50 in premarket trading.

Portfolio Pulse from Nabaparna Bhattacharya

November 21, 2023 | 2:16 pm

XPOF

Xponential Fitness, Inc. (XPOF) has reached a significant milestone by opening its 3,000th studio, CycleBar Loveland, in Colorado. CEO Anthony Geisler thanked franchisees and employees for their contributions to this achievement. Xponential Fitness has a presence in 23 countries and plans for continued growth. The owners of CycleBar Loveland, Sydnie and Zack Whitmer, expressed gratitude for Xponential's support and commitment to providing exceptional fitness experiences.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:10 pm

SNDX

Syndax Pharmaceuticals announced that data from its pivotal AUGMENT-101 trial of Revumenib for treating relapsed/refractory KMT2Ar acute leukemia has been selected for a late-breaking presentation at the 65th ASH Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:09 pm

SCLX

Scilex Holding Company (NASDAQ:SCLX) announced an increase in manufacturing of ELYXYB, a non-opioid pain management product for migraines, to meet rising demand. The company has produced its first commercial batch with Scilex labeled ELYXYB, aiming to address the needs of future customers. ELYXYB is FDA-approved and has shown effectiveness in clinical trials. The U.S. migraine drug market is estimated at $4.1 billion in 2022. Scilex's CEO expressed excitement about ELYXYB's potential since its April 2023 launch.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:09 pm

SPR

Skyrora and Spirit AeroSystems have announced a collaboration to enhance the UK's orbital launch capabilities. Skyrora aims to be the first UK company to launch satellites from UK soil, with up to 16 launches per year planned. The partnership will leverage Spirit's manufacturing and testing facilities in the UK to transition Skyrora's vehicles from development to full-scale production. The collaboration aligns with the UK Government's National Space Strategy to become Europe's leading provider of small satellite launch by 2030. The partnership also includes research in space technologies, such as additive manufacturing, with Skyrora providing access to its Skyprint 2 3D printer.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:08 pm

NVDA

WIT

Wipro has partnered with NVIDIA to leverage generative AI for healthcare insurance companies, utilizing NVIDIA's AI Enterprise software. This collaboration combines the strengths of both companies in AI and large language models to innovate in the healthcare insurance sector.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:08 pm